MedTrace Logo

Assessment of Minimally Invasive Surgery for Esophageal Cancer

NCT05662644 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2022-12-22

No results posted yet for this study

Summary

Evaluate the feasibility and outcome of minimally invasive management of esophageal cancer regarding

1. Surgical technique:

A totally minimally invasive technique (combined thoracoscopic and laparoscopic approaches) for esophagectomy will be used in this study. Also, a hybrid technique (thoracoscopic approach with laparotomy or laparoscopic approach with thoracotomy) will be included.
2. Histopathology

* Assessment of surgical margins
* Assessment of the number of lymph nodes
3. Peri-operative outcome including

* Operative time
* Conversion to open
* Blood loss
* Hospital stays
4. Evaluation of recurrence, disease-free survival and overall survival rates: according to The Kaplan-Meier estimator
5. Morbidity and mortality.

Conditions

  • Esophageal Cancer

Interventions

PROCEDURE

Minimally Invasive Surgery for Esophageal Cancer

Assessment of minimally Invasive Surgery for Esophageal Cancer

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Principal Investigators

  • Ahmed A Kenawy, MD · Sohag University

  • Alaa-Eldin H Mohamed, professor · Sohag University

  • Alaa A Redwan, professor · Sohag University

  • Haitham F Othman, MD · National Cancer Institute (NCI)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-31
Primary Completion
2023-12-31
Completion
2024-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05662644 on ClinicalTrials.gov